Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Translational Stroke Research

Volumn 3, Issue SUPPL. 1, 2012, Pages 88-93

  Keric, Naureen ^a,b   Maier, Gerrit Steffen ^a,b   Samadani, Uzma ^a,c   Kallenberg, Kai ^a   Dechent, Peter ^a   Brueck, Wolfgang ^a   Heuer, Jan ^a   Rohde, Veit ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c New York School of Medicine   (United States)

Author keywords

Animal model; Intracerebral hemorrhage; Lysis; Pig; Plasminogen activator inhibitor 1; Porcine; Recombinant tissue plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; EXPERIMENTAL PIG; MALE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SURGICAL DRAINAGE;

EID: 84862246165     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0188-3     Document Type: Article

References (31)

1. Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM, Qureshi AI. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Res. 2002; 24(1): 58-62.
2. Nilsson OG, Lindgren A, Brandt L, Saveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg. 2002; 97: 531-6.
3. Schutz H, Bodeker RH, Damian M, Krack P, Dorndorf W. Age-related spontaneous intracerebral hematoma in a German community. Stroke. 1990; 21: 1412-8.
4. Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc. 2005; 80: 420-33.
5. Hardemark HG, Wesslen N, Persson L. Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovasc Dis. 1999; 9: 10-21.
6. Carvi MN, Haas E, Hollerhage HG, Schneider H, Pollath A, Archavlis E. Combined minimal invasive techniques in deep supratentorial intracerebral haematomas. Minim Invasive Neurosurg. 2004; 47: 294-8.
7. Thiex R, Kuker W, Muller HD, Rohde I, Schroder JM, Gilsbach JM, Rohde V. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Neurol Res. 2003; 25: 254-62.
8. Wagner KR, Xi Guohua Y, Zuccarello M, de Courten-Myers GM, Broderick JP, et al. Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg. 1999; 90: 491-8.
9. Rohde V, Uzma N, Rohde I, St Clair E, Samadani U. Fibrinolytic therapy versus craniotomy for anticoagulant-associated intracerebral hemorrhage. Clin Neurol Neurosurg. 2009; 111(6): 518-22.
10. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tisuue plasminogen activator for lysis of intraventricular hemorrhage. J Neurol Neurosurg Psychiatry. 1995; 58: 447-51.
11. Rohde V, Rohde I, Thiex R, Ince A, Jung A, Duckers G, et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg. 2002; 97: 954-62.
12. Hoff JT, Xi G. Brain edema from intracerebral hemorrhage. Acta Neurochir. 2003; 86: 11-5.
13. Thiex R, Kuker W, Jungbluth P, Kayser C, Muller HD, Rohde I, Gilsbach JM, Rohde V. Minor inflammation after surgical evacuation compared with fibrinolytic therapy of experimental intracerebral hemorrhages. Neurol Res. 2005; 27: 493-8.
14. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke. 1996; 27: 490-7.
15. Tsuchiya K, Mizutani Y, Hachiya J. Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors. Am J Neuroradiol. 1996; 17(6): 1081-6.
16. Kothari R, Pancioli A, Brott T, Broderick J. Thrombolytic therapy for cerebral infarction. Acad Emerg Med. 1996; 3(9): 881-92.
17. Schaller C, Rohde V, Meyer B, Hassler W. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery. 1995; 36(2): 328-33.
18. Teernstra OP, Evers SM, Lodder J, Leffers P, Franke CL, Blaauw G. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke. 2003; 34(4): 968-74.
19. Tsirka SE. Clinical implications of the involvement of tPA in neuronal cell death. J Mol Med. 1997; 75(5): 341-7.
20. Figueroa BE, Keep RF, Betz AL, Hoff JT. Plasminogen activators potentiate thrombin-induced brain injury. Stroke. 1998; 29(6): 1202-7.
21. Wang X, Asahi M, Lo EH. Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci Lett. 1999; 274(2): 79-82.
22. Goto H, Fujisawa H, Oka F, Nomura S, Kajiwara K, Kato S, Fujii M, Maekawa T, Suzuki M. Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain. J Neurotrauma. 2007; 24: 745-52.
23. Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci. 1999; 112: 4007-16.
24. Siao CJ, Tsirka SE. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci. 2002; 22: 3352-8.
25. Mori T, Wang X, Kline AE, Siao CJ, Dixon CE, Tsirka SE, et al. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport. 2001; 12: 4117-20.
26. Thiex R, Weis J, Krings T, Barreiro S, Yakisikli-Alemi F, Gilsbach JM, et al. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages. J Neurosurg. 2007; 106: 314-20.
27. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest. 2003; 112: 1533-40.
28. Chen B, Cheng Q, Yang K, Lyden PD. Thrombin mediates severe neurovascular injury during ischemia. Stroke. 2010; 41(10): 2348-52. Epub 2010 Aug 12.
29. Hua Y, Xi G, Keep RF, Wu J, Jiang Y, Hoff JT. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2002; 22: 55-61.
30. Armstead WM, Nassar T, Akkawi S, Smith DH, Chen XH, Cines DB, et al. Neutralizing the neurotoxic effects of exogenous and endogenous tPA. Nat Neurosci. 2006; 9: 1150-5.
31. Soeda S, Koyanagi S, Kuramoto Y, Kimura M, Oda M, Kozako T, et al. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost. 2008; 100(6): 1014-20. Review.